Gilead Sciences Stock Alpha and Beta Analysis

GILD Stock  USD 89.76  1.13  1.27%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Gilead Sciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Gilead Sciences over a specified time horizon. Remember, high Gilead Sciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Gilead Sciences' market risk premium analysis include:
Beta
0.46
Alpha
0.23
Risk
1.44
Sharpe Ratio
0.19
Expected Return
0.27
Please note that although Gilead Sciences alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Gilead Sciences did 0.23  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Gilead Sciences stock's relative risk over its benchmark. Gilead Sciences has a beta of 0.46  . As returns on the market increase, Gilead Sciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Gilead Sciences is expected to be smaller as well. At present, Gilead Sciences' Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 7.87, whereas Tangible Book Value Per Share is projected to grow to (9.15).

Enterprise Value

106.55 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Gilead Sciences Backtesting, Gilead Sciences Valuation, Gilead Sciences Correlation, Gilead Sciences Hype Analysis, Gilead Sciences Volatility, Gilead Sciences History and analyze Gilead Sciences Performance.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.

Gilead Sciences Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Gilead Sciences market risk premium is the additional return an investor will receive from holding Gilead Sciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Gilead Sciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Gilead Sciences' performance over market.
α0.23   β0.46

Gilead Sciences expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Gilead Sciences' Buy-and-hold return. Our buy-and-hold chart shows how Gilead Sciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Gilead Sciences Market Price Analysis

Market price analysis indicators help investors to evaluate how Gilead Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Gilead Sciences shares will generate the highest return on investment. By understating and applying Gilead Sciences stock market price indicators, traders can identify Gilead Sciences position entry and exit signals to maximize returns.

Gilead Sciences Return and Market Media

The median price of Gilead Sciences for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 84.67 with a coefficient of variation of 6.39. The daily time series for the period is distributed with a sample standard deviation of 5.42, arithmetic mean of 84.79, and mean deviation of 4.18. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
 
Gilead Sciences dividend paid on 27th of September 2024
09/27/2024
1
Gilead Sciences chief medical officer sells 2.34 million in stock
11/07/2024
2
Gilead Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention at HIV Glasgow
11/13/2024
3
Apollon Wealth Management LLC Sells 276 Shares of Gilead Sciences, Inc.
11/14/2024
4
Gileads Livdelzi Demonstrated a Sustained Efficacy and Long-Term Safety Profile in Management of Primary Biliary Cholangitis
11/15/2024
5
Gilead Sciences shares target upgraded, holds rating on HIV event outlook
11/18/2024
6
Gilead Sciences Issues 3.5 Billion in Senior Notes
11/20/2024

About Gilead Sciences Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Gilead or other stocks. Alpha measures the amount that position in Gilead Sciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Dividend Yield0.03950.03440.03770.0268
Price To Sales Ratio3.343.953.733.54

Gilead Sciences Upcoming Company Events

As portrayed in its financial statements, the presentation of Gilead Sciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Gilead Sciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Gilead Sciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Gilead Sciences. Please utilize our Beneish M Score to check the likelihood of Gilead Sciences' management manipulating its earnings.
6th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Gilead Sciences

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports:
Gilead Sciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Gilead Sciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Gilead Sciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...